Androgen prostate

Glucocorticoids have inhibitory (apoptotic) effects on lymphocyte proliferation and are used to treat leukemias and lymphomas. Estrogens (fosfestrol) are used to block the effect of androgens in prostate cancer. Progestogens (megestrol, medroxyprogesteroneacetate) have been useful for treating endometrial carcinoma, renal tumors, and breast cancer. 

Hormone antagonists (tamoxifen and toremifen bind to the estradiol receptor, flutamide binds to the androgen receptor) are used for treating breast and prostate cancer. 

Androgens act via the AR and play an important role in the development and differentiation of the male sexual organ. Furthermore, they are involved in several diseases, the most important being partial and complete androgen insensitivity syndrome (AIS formerly known as the testicular feminization syndrome), spinal and bulbar muscle atrophy (SBMA Kennedy s disease), and the neoplastic transformation of the prostate. The two natural occurring androgens are testosterone (T) and the... 

The adult male prostate contains abundant acid phosphatase which it secretes into the semen. The production of this enzyme is governed by the circulating levels of androgenic hormones. Castration or estrogen administration markedly reduces the prostatic urinary acid phosphatase of males. Other organs such as the liver, kidney, spleen, red cells and platelets also contain significant amounts of acid phosphatase. 

Cha, T.L. et al., Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth, Cancer Res., 65, 2287, 2005. 

In an enlarged gland, the epithelial/stromal tissue ratio is 1 5.3 Androgens stimulate epithelial, but not stromal tissue hyperplasia. Hence, androgen antagonism does not induce a complete reduction in prostate size to normal. This explains one of the limitations of the clinical effect of 5a-reductase inhibitors. 

The antiandrogens block androgen receptors to inhibit the action of testosterone and dihydrotestosterone in prostate... 

Contrast the benefits and risks of luteinizing hormone-releasing hormone (LHRH) singleagent therapy and combined androgen blockade in the first-line therapy of metastatic prostate cancer. 

Androgen ablation with a luteinizing hormone-releasing hormone (LHRH) agonist plus an antiandrogen should be used prior to radiation therapy for patients with locally advanced prostate cancer to improve outcomes over radiation therapy alone. 

Genetic Familial prostate cancer is inherited in an autosomal dominant manner. Mutations in p53, Rb, E-cahedrin, a-catenin, androgen receptor, KAII, microsatellite instability, loss of heterozygocity at 1, 2q, 12p, 15q, 16p, and 16q. Candidate prostate cancer gene locus identified on chromosome 1. 

CAG repeat length. Shorter CAG repeat sequences have been found in African Americans. Therefore, the combination of increased testosterone and increased androgen receptor activation may account for the increased risk of prostate cancer for African-American men.2 The Asian diet generally is considered to be low in fat and high in fiber with a high concentration of phytoestrogens, potentially explaining the decreased risk in Asians.4... 

The growth and development of the prostate is under control of androgens, and it is well known that men who undergo castration prior to puberty do not develop prostate cancer. The... 

---